Increasing Risk of Gestational Syphilis Fuels Demand in Syphilis Diagnostics Market

The research analysts at Transparency Market Research project that the global syphilis immunoassay market will rise from its evaluation in 2018 i.e. US$ 310 million to hit the mark of US$ 380 million by the end of the forecast period in 2027. They also predict that the global syphilis immunoassay market will witness a CAGR of 2 % over the forecast period of 2019 to 2027. Rising instances of sexually transmitted diseases along with increasing awareness and concerns regarding the mother to child transmission of gestational syphilis are likely to drive the demand in the global syphilis immunoassay market in coming years.

Advantages of ready to use reagents such as avoiding the time consumption required for dilution, pipetting, and calculation along with qualities of preventing contamination are boosting the demand for the products in the global syphilis immunoassay market. Products offered by the players and manufacturers operating within the global syphilis immunoassay market include analyzers, and kits and reagents. Rising number of one time use reagents as well as tests are expected to fuel the demand for kits and reagents in the global syphilis immunoassay market over the forecast period. Furthermore, new approaches of machine learning and technology enabled automation are being implemented to develop novel diagnostic systems in the global syphilis immunoassay market.

Low Turnaround Time and High Efficiency Benefits Boost Demand for CLIA Tests in Syphilis Immunoassay Market

Technological advancements in the global syphilis immunoassay market are enabling medical practitioners in bridging the gaps for efficient diagnostics. This trend is supplementing the growth of the global syphilis immunoassay market. Segments in the global syphilis immunoassay market on the basis of technology include CLIA and ELISA, among others. Low turnaround time and high efficiency of CLIA technology is anticipated to increase the uptake of CLIA tests in the global syphilis immunoassay market during the forecast period. Enhancements in the analyzer technologies are creating lucrative development opportunities for healthcare providers and players in the global syphilis immunoassay market in coming years.

End users for the products in the global syphilis immunoassay market include hospitals, blood banks, and diagnostic labs, among others. Mandatory requirement for testing of blood donors is fueling the demand from the blood banks segment in the global syphilis immunoassay market in coming years. Increase in the spending capacity of patients living with sexually transmitted infections is also increasing the demand for advanced analyzers from blood banks and hospitals. This trend is expected to motivate the sales in the global syphilis immunoassay market in coming years. Leading regions covered in the study on the global syphilis immunoassay market include North America, Middle East and Africa, Europe, Latin America, and Asia Pacific.

Players in Syphilis Immunoassay Market Engaged in R&D and M&A as Key Strategies

Major incumbent players assessed in the research report on the global syphilis immunoassay market include Bio Rad Laboratories, Inc., Becton, F. Hoffmann la Roche Ltd., DiaSorin S.p.A., Ortho Clinical Diagnostics (part of the Carlyle Group), Biomerieux SA, Danaher, Dickinson and Company, Beckman Coulter, Inc., Siemens Healthineers AG, Abbott Laboratories, Shenzhen New Industries Biomedical Engineering Co. Ltd., and Fujirebio of Miraca Group. Majority of players in the global syphilis immunoassay market are engaged in new product launches, research and development, and mergers and acquisitions as chief strategies for expansion. For example, Abbott Laboratories acquired a provider of diagnostic services and devices called ‘Alere, Inc.’ in October of 2017. Moreover, Gold Standard Diagnostics launched their proprietary technology that performs serological testing for syphilis in April of 2019. Players including Abbott Laboratories, F. Hoffmann La Roche Ltd., DiaSorin S.p.A., and Siemens Healthineers account for more than 50 % industry share in the global syphilis immunoassay market.

Global Syphilis Immunoassay Diagnostics Market: Segmentation

  • Syphilis Immunoassay Diagnostics Market by Product
    • Analyzers
    • Kits & Reagents
  • Syphilis Immunoassay Diagnostics Market by Technology
    • ELISA
    • CLIA
    • Others
  • Syphilis Immunoassay Diagnostics Market by End User
    • Hospitals
    • Blood Banks
    • Diagnostics
    • Others
  • Syphilis Immunoassay Diagnostics Market by Region
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Australia & New Zealand
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Mexico
      • Rest of Latin America
    • Middle East & Africa
      • GCC Countries
      • South Africa
      • Rest of Middle East & Africa

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research,

90 Sate Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com/

7 of 10 large enterprizes view our Report to take the right decision.

View Report